108 related articles for article (PubMed ID: 37399497)
1. Receptor Tyrosine Kinases ror1/2 and ryk Are Co-expressed with Multiple Wnt Signaling Components During Early Development of Sea Urchin Embryos.
Ka C; Gautam S; Marshall SR; Tice LP; Martinez-Bartolome M; Fenner JL; Range RC
Biol Bull; 2021 Oct; 241(2):140-157. PubMed ID: 34706206
[TBL] [Abstract][Full Text] [Related]
2. Progranulin Protects against Hyperglycemia-Induced Neuronal Dysfunction through GSK3β Signaling.
Dedert C; Salih L; Xu F
Cells; 2023 Jul; 12(13):. PubMed ID: 37443837
[TBL] [Abstract][Full Text] [Related]
3. Progranulin is an FMRP target that influences macroorchidism but not behaviour in a mouse model of Fragile X Syndrome.
Life B; Bettio LEB; Gantois I; Christie BR; Leavitt BR
Curr Res Neurobiol; 2023; 5():100094. PubMed ID: 37416094
[TBL] [Abstract][Full Text] [Related]
4. The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment.
Barone D; Iannuzzi CA; Forte IM; Ragosta MC; Cuomo M; Dell'Aquila M; Altieri A; Caporaso A; Camerlingo R; Rigano MM; Monti DM; Barone A; Imbimbo P; Frusciante L; Monda M; D'Angelo M; De Laurentiis M; Giordano A; Alfano L
Front Oncol; 2023; 13():1117262. PubMed ID: 37409248
[TBL] [Abstract][Full Text] [Related]
5. Characterization of KLHL14 anti-oncogenic action in malignant mesothelioma.
Canciello A; Domínguez RB; Barboni B; Giordano A; Morrione A
Heliyon; 2024 Mar; 10(6):e27731. PubMed ID: 38509883
[TBL] [Abstract][Full Text] [Related]
6. The biochemistry, signalling and disease relevance of RYK and other WNT-binding receptor tyrosine kinases.
Roy JP; Halford MM; Stacker SA
Growth Factors; 2018 Apr; 36(1-2):15-40. PubMed ID: 29806777
[TBL] [Abstract][Full Text] [Related]
7. Ryk: another heretical Wnt receptor defies the canon.
Cheyette BN
Sci STKE; 2004 Dec; 2004(263):pe54. PubMed ID: 15598975
[TBL] [Abstract][Full Text] [Related]
8. Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells.
Ventura E; Belfiore A; Iozzo RV; Giordano A; Morrione A
Am J Physiol Cell Physiol; 2023 Aug; 325(2):C391-C405. PubMed ID: 37399497
[TBL] [Abstract][Full Text] [Related]
9. Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.
Berndt JD; Aoyagi A; Yang P; Anastas JN; Tang L; Moon RT
J Cell Biol; 2011 Sep; 194(5):737-50. PubMed ID: 21875946
[TBL] [Abstract][Full Text] [Related]
10. The Wnt receptor Ryk plays a role in mammalian planar cell polarity signaling.
Macheda ML; Sun WW; Kugathasan K; Hogan BM; Bower NI; Halford MM; Zhang YF; Jacques BE; Lieschke GJ; Dabdoub A; Stacker SA
J Biol Chem; 2012 Aug; 287(35):29312-23. PubMed ID: 22773843
[TBL] [Abstract][Full Text] [Related]
11. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin.
Tanimoto R; Palladino C; Xu SQ; Buraschi S; Neill T; Gomella LG; Peiper SC; Belfiore A; Iozzo RV; Morrione A
Matrix Biol; 2017 Dec; 64():27-39. PubMed ID: 28433812
[TBL] [Abstract][Full Text] [Related]
12. The Wnt coreceptor Ryk regulates Wnt/planar cell polarity by modulating the degradation of the core planar cell polarity component Vangl2.
Andre P; Wang Q; Wang N; Gao B; Schilit A; Halford MM; Stacker SA; Zhang X; Yang Y
J Biol Chem; 2012 Dec; 287(53):44518-25. PubMed ID: 23144463
[TBL] [Abstract][Full Text] [Related]
13. Progranulin Oncogenic Network in Solid Tumors.
Ventura E; Ducci G; Benot Dominguez R; Ruggiero V; Belfiore A; Sacco E; Vanoni M; Iozzo RV; Giordano A; Morrione A
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980592
[TBL] [Abstract][Full Text] [Related]
14. Complexity of progranulin mechanisms of action in mesothelioma.
Ventura E; Xie C; Buraschi S; Belfiore A; Iozzo RV; Giordano A; Morrione A
J Exp Clin Cancer Res; 2022 Dec; 41(1):333. PubMed ID: 36471440
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
